Moderna, an American biotech company located in Cambridge, MA.
NASDAQ symbol: MRNA
Their specialty is therapeutics using messenger RNA - specifically, injecting certain proprietary mRNA serums into patients to bolster the person's ability to generate an immune response.
Limited Phase One COVID-19 Vaccine Study:
* Dose dependent response (higher doses of the vaccine = greater immunity)
* 8 / 8 patients showed neutralizing antibodies
* Antibody levels similar to or higher than those persons who have recovered from COVID-19 infections.
* Generally safe and well tolerated
* Phase Three expected to start in July
NASDAQ symbol: MRNA
Their specialty is therapeutics using messenger RNA - specifically, injecting certain proprietary mRNA serums into patients to bolster the person's ability to generate an immune response.
Limited Phase One COVID-19 Vaccine Study:
* Dose dependent response (higher doses of the vaccine = greater immunity)
* 8 / 8 patients showed neutralizing antibodies
* Antibody levels similar to or higher than those persons who have recovered from COVID-19 infections.
* Generally safe and well tolerated
* Phase Three expected to start in July
Last edited:
I jest.